Floatz logo

TESTOSTERONE UNDECYLATE

Testicular Cancer

University Medical Center GroningenSmall moleculePhase 2/3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Testicular Cancer cohort.

Asset / SponsorPhaseRating
Flavopiridol
National Cancer Institute (NCI)
Phase 2B
FLUOROURACILUM
National Cancer Institute (NCI)
Phase 2B
Etarfolatide
Endocyte
Phase 2B
Eloxatin
National Cancer Institute (NCI)
Phase 2B
Durvalumab
Ludwig Institute for Cancer Research
Phase 1/2CCC

View all 20 →

Same molecule, other indications

TESTOSTERONE UNDECYLATE is also rated in:

hypogonadotropic hypogonadismDormant
A
Indicative ·
82 / 100
View asset →
type 2 diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →